PHA Classroom: e-Learning. Anytime. Anyplace.


>>Back to All Recordings

>>Back to About PH Recordings
>>Back to 2012 Conference Session Recordings

Session Recording from PHA's 2012 10th International PH Conference
Guinea Pig or Hero – The Journey through Clinical Trials

June 23, 2012

Clinical trials in pulmonary arterial hypertension have led to the FDA approval of nine medicines over the past 17 years! This is great for the community as a whole, but what is it like for an individual patient to participate in a research trial? Experienced researchers will discuss the benefits and potential risks of clinical trials.

Presenter Information

Karen Fagan, MD, University of South Alabama, Mobile, Ala. (Chair); Serpil Erzurum, MD, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio; Jeremy Feldman, MD, Arizona Pulmonary Specialists, LTD, Phoenix, Ariz.; Steven Kawut, MD, Pereleman School of Medicine, University of Pennsylvania, Philadelphia, Pa.

 

 

 

DIAMOND
SUPPORTER

PLATINUM
SUPPORTER

GOLD
SUPPORTER

SILVER
SUPPORTER

Actelion Pharmaceuticals US, Inc. Gilead Sciences, Inc. United Therapeutics Corporation Bayer HealthCare
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.

 

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

For the best viewing experience of this site, it is recommended that you use Internet Explorer 8 or 9 or Firefox.

© 2014 Pulmonary Hypertension Association. All Rights Reserved.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
Webmaster@PHAssociation.org
    Privacy Policy   Virtual Tour of Website    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.®

NORD

The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.